WASHINGTON D.C. – A groundbreaking new study published by the Institute for Advanced Medical Inaccessibility (IAMI) reveals that a patient's zip code, specifically its distance from a bespoke gene therapy facility, is now the leading determinant of who receives life-altering treatment. The report, titled 'Geographic Determinants of Genetic Destiny: A Post-Scarcity Paradox,' indicates a direct correlation between treatment access and the presence of a 'Platinum-Tier Bio-Lounge' within a 15-mile radius.

'We've always known that gene therapy was prohibitively expensive, but we underestimated the logistical hurdles of delivering a bespoke, multi-million-dollar treatment that requires a clean room environment comparable to a microchip factory and a post-operative suite with artisanal kombucha on tap,' stated Dr. Quentin Quibble, Lead Cartographer of Medical Despair at IAMI. 'It turns out, if you don't live within a short, non-commute-hour drive of such a facility, the gene simply... won't gene.'

The study found that patients residing in 'Therapeutic Deserts' – areas without immediate access to a 'Concierge Gene Infusion Center' – experienced a 97.4% reduction in successful treatment outcomes, largely due to the 'sheer inconvenience' of travel. 'We had one patient who lived 27 miles away,' recounted Nurse Brenda 'The Bouncer' Bellows from the exclusive 'Helix Haven' clinic. 'By the time they navigated traffic, the genetically engineered viral vector had already started playing solitaire on its own. We just can't risk that kind of therapeutic degradation.'

Experts now recommend that individuals seeking future gene therapy relocate preemptively to designated 'Wellness Enclaves' or consider investing in personal, climate-controlled medical drones.